C. Patrono

Cardiology and Cardiovascular Medicine · 2001–2021

A researcher in the Science corpus: 12 papers; trusts 1 researcher and is trusted by 3 researchers here, as inferred from the citation graph.

Subfields

Whom C. Patrono trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

  1. M. Roncaglioni
  2. Zaverio M. Ruggeri

Who trusts C. Patrono overall

  1. S. Jackson
  2. V. Basevi
  3. Alexander Zarbock

Papers from C. Patrono's perspective

Ordered by how strongly the researchers C. Patrono trusts endorse each paper. Same corpus, a different order for every researcher.

  1. Mapping neutralizing and immunodominant sites on the SARS-CoV-2 spike receptor-binding domain by structure-guided high-resolution serology
  2. Safety and Immunogenicity of SARS-CoV-2 mRNA-1273 Vaccine in Older Adults (New England Journal of Medicine)
  3. EFFECTS OF CLOPIDOGREL IN ADDITION TO ASPIRIN IN PATIENTS WITH ACUTE CORONARY SYNDROMES WITHOUT ST-SEGMENT ELEVATION
  4. Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial. (Journal of the American Medical Association (JAMA))
  5. Cardiac Troponin T Measured by a Highly Sensitive Assay Predicts Coronary Heart Disease, Heart Failure, and Mortality in the ARIC Study (Circulation)
  6. [Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban]. (Italian heart journal. Supplement : official journal of the Italian Federation of Cardiology)
  7. ACC/AHA 2002 guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction--summary article: a report of the American College of… (Journal of the American College of Cardiology)
  8. In-stent restenosis in the drug-eluting stent era. (Journal of the American College of Cardiology)
  9. Comparison of two platelet glycoprotein IIb/IIIa inhibitors, tirofiban and abciximab, for the prevention of ischemic events with percutaneous coronary revascularization. (New England Journal of Medicine)
  10. Rosuvastatin in older patients with systolic heart failure. (Current Atherosclerosis Reports)

Their papers